Biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals

Sectors
Healthcare
Life Sciences
First Invested
2012
Public/PIPES
Company Status
IPO/Public
NASDAQ: ALIM